SBIR-STTR Award

Human Brown Adipocyte Transplantation and in Vivo Metabolic Characterization
Award last edited on: 7/19/2021

Sponsored Program
STTR
Awarding Agency
DOD : DHA
Total Award Amount
$1,847,262
Award Phase
2
Solicitation Topic Code
A11a-T034
Principal Investigator
Olivier Boss

Company Information

Energesis Pharmaceuticals Inc

One Kendall Square Building 200 Suite 2203
Cambridge, MA 02139
   (617) 437-0881
   info@energesispharma.com
   www.energesispharma.com

Research Institution

----------

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2011
Phase I Amount
$98,942
Obesity and its associated metabolic complications including diabetes are becoming increasingly prevalent in the general population as well as in military personnel. Brown adipose tissue (BAT) is a major site of energy expenditure through thermogenesis, which is mediated by the mitochondrial uncoupling protein-1 (UCP1). Studies in animals over the last 30 years as well as recent data in humans strongly suggest that overweight and obese individuals have a low amount of BAT, and that increasing BAT by about 50 grams in obese patients would induce strong weight loss and improve metabolic status (including glucose metabolism, lipid profiles, and cardiovascular risk). This proposal is a feasibility study to define a prototype source and culture system for the generation of human BAT for autologous transplantation therapy. We have recently identified a brown adipocyte progenitor cell population in human muscle, and propose to isolate and characterize the best brown adipocyte progenitor sub-population from human muscle biopsies, expand these cells, and establish the optimal conditions for in vitro differentiation that can generate approximately 50 grams of BAT cells for transplantation.

Keywords:
Obesity, Diabetes, Metabolic Disease, Cholesterol, Cell Therapy, Tissue Engineering, Thermogenesis, Brown Adipose Tissue

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2012
(last award dollars: 2015)
Phase II Amount
$1,748,320

Obesity and its associated metabolic complications including diabetes are becoming increasingly prevalent in the general population as well as in military personnel. Brown adipose tissue (BAT) is a major site of energy expenditure through thermogenesis, which is mediated by the mitochondrial uncoupling protein-1 (UCP1). Studies in animals over the last 30 years as well as recent data in humans strongly suggest that overweight and obese individuals have a low amount of BAT, and that increasing BAT by about 50 grams in obese patients would induce strong weight loss and improve metabolic status (including glucose metabolism, lipid profiles, and cardiovascular risk). The proposed studies aim to develop a prototype system for the transplantation of autologous brown adipocytes. We intend to demonstrate that a readily generated population of human brown adipocytes can be transplanted into an animal model of human obesity and insulin resistance, and that these cells can survive and produce significant improvements in glycemic control and body composition (e.g., body weight, fat mass).

Keywords:
obesity, diabetes, metabolic disease, cell transplantation, cell therapy, tissue engineering, thermo